Show Summary Details
Page of

Treatments for Neurological or Psychiatric Disorders: Principles of Central Nervous System Drug Development 

Treatments for Neurological or Psychiatric Disorders: Principles of Central Nervous System Drug Development
Chapter:
Treatments for Neurological or Psychiatric Disorders: Principles of Central Nervous System Drug Development
Author(s):

Leslie L. Iversen

, Susan D. Iversen

, Floyd E. Bloom

, and Robert H. Roth

DOI:
10.1093/med/9780195380538.003.0363
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 05 June 2020

This chapter briefly reviews the complex processes leading from drug discovery of a potential new central nervous system (CNS) drug to registration and market launch. The six major phases of research and development activity involved can be summarized as follows: Drug discovery / preclinical / phase I / phase II / phase III / registration

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.